Panel Detail

Sunday, September 9, 2012
8:40 AM - 9:30 AM

Translation, Innovation and Commercialization: Role of the NCI's Comprehensive Cancer Centers


Anna Barker, Director, Arizona State University Transformative Healthcare Networks; Co-director of the Complex Adaptive Systems Initiative; Former Deputy Director, National Cancer Institute


Ronald DePinho, President, The University of Texas MD Anderson Cancer Center
Stephen Gruber, Director, USC Norris Comprehensive Cancer Center, University of Southern California
William Nelson, Director, Kimmel Comprehensive Cancer Center at Johns Hopkins
Steve Rosen, Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Current progress in defining genomic and molecular changes in tumors is creating new opportunities to drive drug discovery, assign patients to clinical trials, and, if successful, will provide a foundation for more-precise and personalized cancer medicine. Innovative, computationally-focused and other approaches to this data "tsunami" are needed to maximize its potential. But these approaches must also incorporate new translational research models that include networks of academic, public and private sector organizations along with the creation of innovation centers that enable commercialization of emerging technologies. The NCI comprehensive cancer centers represent a powerful national network with the capabilities needed to achieve much of this vision. In doing so, they promise to produce an additional benefit - more-robust hubs of regional economic development. Is this an achievable vision? If so, how can progress be accelerated? If not, what should the NCI (and the cancer centers) do to enable its achievement?

Panel Video

th translation

Click image above to play video